World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
75
Citations
17335
World Ranking
5402
National Ranking
417

Medicine

D-Index
75
Citations
18209
World Ranking
19191
National Ranking
1733

Overview

John R. Atack is a researcher affiliated with Cardiff University in the United Kingdom. Their work primarily spans the fields of Biochemistry, Genetics and Molecular Biology, Neuroscience, and Medicine, with a significant focus on Molecular Biology and Cellular and Molecular Neuroscience.

Their recent scholarly output includes a variety of publications across multiple reputable venues. Notable papers include:

  • Relating neurosteroid modulation of inhibitory neurotransmission to behaviour, 2021, Journal of Neuroendocrinology
  • Multi-patient dose synthesis of [18F]Flumazenil via a copper-mediated 18F-fluorination, 2022, EJNMMI Radiopharmacy and Chemistry
  • Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity, 2022, Journal of Medicinal Chemistry
  • A toolkit for the identification of NEAT1_2/paraspeckle modulators, 2022, Nucleic Acids Research
  • Inhibition of a tonic inhibitory conductance in mouse hippocampal neurones by negative allosteric modulators of α5 subunit-containing γ-aminobutyric acid type A receptors: implications for treating cognitive deficits, 2020, British Journal of Anaesthesia

John R. Atack frequently collaborates with a consistent group of co-authors. These include Simon E. Ward, Jason A. Gillespie, Loren Waters, Olivera Grubisha, and Karen T Elvers, all of whom have co-authored multiple works with them.

Their publication activity is concentrated in prominent journals such as the Journal of Medicinal Chemistry, bioRxiv (Cold Spring Harbor Laboratory), Journal of Neuroendocrinology, Nucleic Acids Research, and Neuroscience Letters.

The core topics addressed in their research encompass:

  • Neuroscience and Neuropharmacology Research
  • Enzyme Structure and Function
  • Amino Acid Enzymes and Metabolism
  • Cellular Mechanics and Interactions
  • Cardiomyopathy and Myosin Studies
  • Protein Kinase Regulation and GTPase Signaling
  • Neuroendocrine regulation and behavior

Within their molecular and cellular studies, John R. Atack focuses on aspects such as enzyme mechanisms, receptor modulation, and chemical synthesis related to neuropharmacological functions. Their publications reveal interdisciplinary approaches combining biochemistry, molecular biology, and medicinal chemistry, particularly emphasizing enzyme and receptor activity regulation relevant to neurobiology.

Best Publications

  • Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

    R M McKernan;T W Rosahl;D S Reynolds;C Sur

  • Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

    E K Perry;M Curtis;D J Dick;J M Candy

  • Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor

    Neil Collinson;Frederick M. Kuenzi;Wolfgang Jarolimek;Karen A. Maubach

  • Aluminosilicates and senile plaque formation in Alzheimer's disease.

    J.M. Candy;J. Klinowski;R.H. Perry;E.K. Perry

  • Cerebrospinal fluid production is reduced in healthy aging.

    C. May;J. A. Kaye;John R. Atack;M. B. Schapiro

  • Sedation and Anesthesia Mediated by Distinct GABAA Receptor Isoforms

    David S. Reynolds;Thomas W. Rosahl;Jennifer Cirone;Gillian F. O'Meara

  • Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus.

    Cyrille Sur;Sophie J. Farrar;Julie Kerby;Paul J. Whiting

  • Evidence for a Significant Role of α3-Containing GABAA Receptors in Mediating the Anxiolytic Effects of Benzodiazepines

    Rebecca Dias;Wayne F. A. Sheppard;Rosa L. Fradley;Elizabeth M. Garrett

  • An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

    G. R. Dawson;K. A. Maubach;N. Collinson;M. Cobain

  • Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: Selective loss of the intermediate (10S) form

    John R. Atack;Elaine K. Perry;James R. Bonham;Robert H. Perry

  • Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice.

    Cyrille Sur;Keith A. Wafford;David S. Reynolds;Karen L. Hadingham

  • TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.

    John R. Atack;Keith A. Wafford;Spencer J. Tye;Susan M. Cook

  • Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates.

    James K. Rowlett;Donna M. Platt;Snjezana Lelas;John R. Atack

  • Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System

    John R. Atack;Elaine K. Perry;James R. Bonham;John M. Candy

  • The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics.

    John R Atack

  • Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study.

    Peter J. Whitehouse;A. M. Martino;M. V. Wagster;D. L. Price

  • The complexity of the GABAA receptor shapes unique pharmacological profiles.

    Charlotte D’Hulst;John R. Atack;R. Frank Kooy

  • Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.

    Pascal Bonaventure;Lisa Kelly;Leah Aluisio;Jonathan Shelton

  • L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors

    John R. Atack;Peter J. Bayley;Guy R. Seabrook;Keith A. Wafford

  • Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.

    Alison J. Smith;Luanda Alder;Jonathan Silk;Charles Adkins

Frequent Co-Authors

Ruth M. McKernan
Ruth M. McKernan MSD (United States)
Keith A. Wafford
Keith A. Wafford Eli Lilly (United States)
Gerard R. Dawson
Gerard R. Dawson P1vital LTD
Paul J. Whiting
Paul J. Whiting University College London
Richard Hargreaves
Richard Hargreaves Harvard Medical School
Thomas W. Rosahl
Thomas W. Rosahl MSD (United States)
Angus Murray Macleod
Angus Murray Macleod MSD (United States)
Elaine K. Perry
Elaine K. Perry Newcastle University
Robert H. Perry
Robert H. Perry Newcastle University
Stanley I. Rapoport
Stanley I. Rapoport National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing John R. Atack

Trending Scientists

Recently Published Articles